ANDREW MCDOWELL: Open Payments
NPI 1821767559 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,090 in 213 payments from 20 companies in 2025. Trend: 2023 $1,035 · 2024 $3,025 · 2025 $4,090
Food & beverage: $4,080Education: $10
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 64 | $1,153 |
| Janssen Biotech, Inc. | 34 | $534 |
| Madrigal Pharmaceuticals | 20 | $457 |
| Takeda Pharmaceuticals U.S.A., Inc. | 21 | $438 |
| Lilly USA, LLC | 16 | $353 |
| GENZYME CORPORATION | 7 | $237 |
| Ardelyx, Inc. | 11 | $226 |
| Pharmacosmos Therapeutics Inc. | 2 | $158 |
| Phathom Pharmaceuticals, Inc. | 17 | $141 |
| Celltrion USA Inc. | 4 | $68 |
Products named: TREMFYA, RINVOQ, REZDIFFRA, ENTYVIO, OMVOH, SKYRIZI, DUPIXENT, IBSRELA.
Industry payments across OK — which companies pay providers there.
